Alzheon

Alzheon is a biotech company in Framingham, United States, founded in 2013. It has raised $100.0M across 1 round, most recently a $100.0M Series E in June 2024.

Preserving future memories

Founded
2013
Total Funding
$100.0M
Last Round
$100.0M Series EJun 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Alzheon develops disease-modifying treatments for Alzheimer's disease and other neurodegenerative disorders by targeting protein misfolding and aggregation. Its investigational oral anti-amyloid treatment, valiltramiprosate/ALZ-801, recently completed Phase 3 testing in early symptomatic Alzheimer's disease.

Summary

It has raised $100.0M in total across 1 round, most recently a $100.0M Series E round in Jun 2024.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ESeries EJun 2024
$100.0M

Similar Companies

Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alzheon on Indexed.vc
<a href="https://indexed.vc/companies/alzheon"><img src="https://indexed.vc/api/badge/company/alzheon" alt="Alzheon on Indexed.vc" width="260" height="76" /></a>